Ibrance 75 MG capsule 21S
Ended Awarded Last action
- Contract number
- SPE2DR26FQQ9D
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $17,123
Award facts
- Contract value 100% obligated
- $17,122.82 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $17,122.82 to AmerisourceBergen Drug Corp for the supply of Ibrance 75 mg capsules (21-count units) on November 25, 2025, with an ultimate completion date of December 17, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the awardee's Conshohocken, Pennsylvania location. The delivery order falls under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle enabling supply of medications and medical commodities to military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical federal vendor for medical procurement across the Defense Health System. The company's extensive portfolio of federal contracts demonstrates its capability to deliver a broad spectrum of pharmaceutical products including brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. This particular delivery order for Ibrance, a oncology medication used in cancer treatment, represents a routine transaction within the company's ongoing federal pharmaceutical supply operations supporting military and veteran healthcare systems.
Quick answers
Who was awarded contract SPE2DR26FQQ9D?
SPE2DR26FQQ9D was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 25, 2025.
How much is contract SPE2DR26FQQ9D worth?
The government has obligated $17,123 on SPE2DR26FQQ9D.
Is contract SPE2DR26FQQ9D an order under another contract?
Yes. SPE2DR26FQQ9D is a delivery order under SPE2DR25D1022, an indefinite delivery contract.
Was contract SPE2DR26FQQ9D competed?
The extent of competition for SPE2DR26FQQ9D was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award